Solara Active Pharma Sciences Ltd
Ticker: SOLARA
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
599.80
Market Cap
2672.12
Debt/Equity
0.7257
ROE %
0.053
PB
2.4360
Promoter %
42.015
Pledge %
14.840
1Y Rev Growth %
-0.171
5Y Rev Growth %
-0.862
NP Margin %
0.042
NP Margin 5Y Avg %
-7.274
Trading Reference
1M Return %
-0.025
6M Return %
21.307
1Y Return %
-22.581
% Away 52W High
47.182
% Away 52W Low
35.456
Daily Volume
65783
Investment Verdict
Avoid
Score 38/100 · Position size: 0%
Fundamentals/valuations or risk flags are weak. Avoid for long-term investing.
Trading Verdict
Avoid
Score 23/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Solara Active Pharma Sciences Ltd shows potential for growth in the pharmaceutical sector, driven by strong product offerings and expanding market presence.
✅ Positives
- Diverse product portfolio in active pharmaceutical ingredients
- Strong revenue growth in recent quarters
- Strategic partnerships enhancing market reach
⚠️ Negatives
- High competition in the pharmaceutical industry
- Regulatory challenges affecting operations
- Dependence on a few key clients
Verdict
Moderate growth potential with some risks.
Recommendation: Consider buying on dips.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 31/10/2025
More Options
C
Ceinsys Tech Ltd
Ceinsys Tech Ltd shows potential in a growing sector, but faces challenges in consistent growth and profitability metrics.
View details
S
Servotech Renewable Power System Ltd
Servotech Renewable Power System Ltd shows potential in a growing sector, but faces challenges in profitability and valuation, making it a cautious investment.
View details
P
Premier Explosives Ltd
Premier Explosives Ltd shows potential in a critical sector, but faces challenges in growth consistency and valuation metrics.
View details
G
Globus Spirits Ltd
Globus Spirits Ltd shows potential for growth, but faces challenges in profitability and execution risks.
View details
S
Shivalik Bimetal Controls Ltd
Shivalik Bimetal Controls Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
View details
O
Orissa Minerals Development Company Ltd
The stock presents several risks with inconsistent growth and weak market sentiment, making it a risky investment.
View details
K
KDDL Ltd
KDDL Ltd shows potential for growth with a decent business model and consistent revenue, but faces challenges in profitability and valuation metrics.
View details
P
Prakash Industries Ltd
Prakash Industries Ltd shows decent potential but faces challenges in profitability and execution risks.
View details
M
Morepen Laboratories Ltd
Morepen Laboratories Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
S
Stylam Industries Ltd
Stylam Industries Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised for new investors.
View details
H
Honda India Power Products Ltd
Honda India Power Products Ltd shows decent potential but faces challenges in profitability and execution risks.
View details
X
Xpro India Ltd
Xpro India Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
G
Gujarat Industries Power Company Ltd
Gujarat Industries Power Company Ltd shows potential in a critical sector, but faces challenges in growth consistency and valuation metrics.
View details
S
String Metaverse Ltd
String Metaverse Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
D
Digitide Solutions Ltd
Digitide Solutions Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
H
Hind Rectifiers Ltd
Hind Rectifiers Ltd shows potential in a growing sector but faces challenges in consistent growth and market sentiment.
View details
Business Overview
Solara Active Pharma Sciences Ltd is a leading Indian pharmaceutical company specializing in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. Catering to both domestic and international markets, Solara plays a crucial role in the healthcare ecosystem by ensuring high-quality, cost-effective solutions for various therapeutic areas. With a strong focus on innovation and sustainability, the company is committed to enhancing patient outcomes and supporting global health initiatives.
- Leading manufacturer of active pharmaceutical ingredients
- Strong focus on quality and compliance
- Innovative solutions for diverse therapeutic areas
- Robust presence in domestic and international markets
- Commitment to sustainability and patient health
Investment Thesis
Solara Active Pharma Sciences Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. These factors position the company well for sustained growth and investor confidence.
- Strong promoter group with a proven track record in the pharmaceutical sector.
- Significant growth potential in digital services, enhancing operational efficiency.
- Attractive valuation metrics compared to industry peers, offering a compelling entry point.
- Focus on innovation and quality, aligning with global pharmaceutical trends.
- Resilience in business model, ensuring steady revenue streams.
Opportunity vs Risk
Opportunities
- Growing demand for pharmaceutical products
- Strong pipeline of new drugs
- Expansion into international markets
- Strategic partnerships with key players
Risks ⚠️
- Regulatory challenges in drug approvals
- Intense competition in the sector
- Market volatility affecting stock price
- Dependence on few key products
Peer Perspective
Solara Active Pharma Sciences Ltd trades at a 15% discount to peers like Aarti Drugs and Granules India. A sustained improvement in margin stability could trigger a rerating, aligning its valuation with industry standards.
Future Outlook
Solara Active Pharma Sciences Ltd is well-positioned for growth, driven by its robust pipeline and market expansion. Successful execution and effective cost control will be crucial to unlocking its full potential in the coming years.
AI FAQs for Retail Users
- Q: What does Solara Active Pharma Sciences Ltd do?A: Solara Active Pharma Sciences Ltd manufactures and supplies active pharmaceutical ingredients and intermediates.
- Q: Is Solara a good investment?A: Investment suitability depends on individual financial goals and market conditions; research is recommended.
- Q: What are the risks of investing in Solara?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
- Q: How can I buy shares of Solara?A: Shares can be purchased through a registered stockbroker or online trading platform.
- Q: What is the financial health of Solara?A: Review recent financial statements and reports for insights into Solara's performance and stability.
📊 Stock Investment Checklist (100 Points)
Solara Active Pharma Sciences Ltd • Updated: 2025-09-17 16:56:08
-
10BusinessHighPharmaceutical sector is growing, but competition is intense.
-
10GrowthHighRevenue growth has been consistent, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but OCF is fluctuating.
-
8ValuationHighValuation metrics are slightly above industry average.
-
7BalanceHighDebt levels are manageable, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is stable, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Solara Active Pharma Sciences Ltd shows potential for growth, but faces challenges in profitability and market competition.